Current Management of Low Risk Differentiated Thyroid Cancer and Papillary Microcarcinoma

被引:24
|
作者
Tarasova, V. D. [1 ]
Tuttle, R. M. [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Med, Serv Endocrinol, 1275 York Ave, New York, NY 10021 USA
关键词
Low risk thyroid cancer; papillary microcarcinoma; staging; BRAF V600E MUTATION; ACTIVE SURVEILLANCE; RADIOACTIVE IODINE; CARCINOMA; ASSOCIATION; RECURRENCE; STRATIFICATION; SURGERY; PROGNOSIS; IMPACT;
D O I
10.1016/j.clon.2016.12.009
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Each year, the proportion of thyroid cancer patients presenting with low risk disease is increasing. Moreover, the definition of low risk thyroid cancer is expanding and several histological subtypes beyond papillary microcarcinomas are now classified as low risk disease. This shift in the landscape of thyroid cancer presentation is forcing clinicians to critically re-evaluate whether or not traditional management paradigms that were effective in treating intermediate and high risk disease are applicable to these low risk patients. Here we review the definition of low risk disease, examine the various histological subtypes that are considered low risk in the 2015 American Thyroid Association guidelines for the management of thyroid nodules and thyroid cancer, and review our current approach to the management of these low risk tumours. (C) 2016 Published by Elsevier Ltd on behalf of The Royal College of Radiologists.
引用
收藏
页码:290 / 297
页数:8
相关论文
共 50 条
  • [31] Papillary microcarcinoma of the thyroid
    Shaha, Ashok R.
    Tuttle, R. Michael
    Shah, Jatin P.
    JOURNAL OF SURGICAL ONCOLOGY, 2007, 95 (07) : 532 - 533
  • [32] Low risk papillary thyroid cancer
    Brito, Juan P.
    Hay, Ian D.
    Morris, John C.
    BMJ-BRITISH MEDICAL JOURNAL, 2014, 348
  • [33] Low-risk papillary microcarcinoma of the thyroid: A review of active surveillance trials
    Ito, Y.
    Miyauchi, A.
    Oda, H.
    EJSO, 2018, 44 (03): : 307 - 315
  • [34] Long-term Outcomes in Low-Risk Differentiated Papillary Thyroid Cancer
    Nixon, Iain J.
    MAYO CLINIC PROCEEDINGS, 2021, 96 (07) : 1700 - 1702
  • [35] Papillary microcarcinoma of the thyroid
    Sugino, K
    Ito, K
    Ozaki, O
    Mimura, T
    Iwasaki, H
    Ito, K
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1998, 21 (07) : 445 - 448
  • [36] Papillary microcarcinoma of the thyroid
    Kiminori Sugino
    K. Ito
    O. Ozaki
    T. Mimura
    H. Iwasaki
    K. Ito
    Journal of Endocrinological Investigation, 1998, 21 : 445 - 448
  • [37] Extrathyroid extension of well-differentiated papillary thyroid microcarcinoma on US
    Kwak, Jin Young
    Kim, Eun-Kyung
    Youk, Ji Hyun
    Kim, Min Jung
    Son, Eun Ju
    Choi, Seon Hyeong
    Oh, Ki Keun
    THYROID, 2008, 18 (06) : 609 - 614
  • [38] Current issues in the management of differentiated thyroid cancer
    Mallick, UK
    Charalambous, H
    NUCLEAR MEDICINE COMMUNICATIONS, 2004, 25 (09) : 873 - 881
  • [39] Indications and Strategy for Active Surveillance of Adult Low-Risk Papillary Thyroid Microcarcinoma: Consensus Statements from the Japan Association of Endocrine Surgery Task Force on Management for Papillary Thyroid Microcarcinoma
    Sugitani, Iwao
    Ito, Yasuhiro
    Takeuchi, Dai
    Nakayama, Hirotaka
    Masaki, Chie
    Shindo, Hisakazu
    Teshima, Masanori
    Horiguchi, Kazuhiko
    Yoshida, Yusaku
    Kanai, Toshiharu
    Hirokawa, Mitsuyoshi
    Hames, Kiyomi Y.
    Tabei, Isao
    Miyauchi, Akira
    THYROID, 2021, 31 (02) : 183 - 192
  • [40] Active surveillance as a management strategy for papillary thyroid microcarcinoma
    Huan Zhang
    Xiangqian Zheng
    Juntian Liu
    Ming Gao
    Biyun Qian
    Cancer Biology & Medicine , 2020, (03) : 543 - 554